Incidence of SARS-CoV-2 infection in patients with multiple sclerosis who received SARS-CoV-2 vaccines and are under treatment with high-efficacy therapies in Argentina.

MLA

Carnero Contentti, Edgar, et al. “Incidence of SARS-CoV-2 Infection in Patients with Multiple Sclerosis Who Received SARS-CoV-2 Vaccines and Are under Treatment with High-Efficacy Therapies in Argentina.” Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, vol. 45, no. 2, Feb. 2024, pp. 379–89. EBSCOhost, https://doi.org/10.1007/s10072-023-07282-x.

APA

Carnero Contentti, E., López, P. A., Pappolla, A., Alonso, R., Silva, B., Deri, N., Balbuena, M. E., Burgos, M., Luetic, G., Alvez Pinheiro, A., Cabrera, M., Hryb, J., Nofal, P., Pestchanker, C., Vrech, C., Tavolini, D., Tkachuk, V., Zanga, G., Marrodan, M., … Rojas, J. I. (2024). Incidence of SARS-CoV-2 infection in patients with multiple sclerosis who received SARS-CoV-2 vaccines and are under treatment with high-efficacy therapies in Argentina. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 45(2), 379–389. https://doi.org/10.1007/s10072-023-07282-x

Chicago

Carnero Contentti, Edgar, Pablo A López, Agustín Pappolla, Ricardo Alonso, Berenice Silva, Norma Deri, María E Balbuena, et al. 2024. “Incidence of SARS-CoV-2 Infection in Patients with Multiple Sclerosis Who Received SARS-CoV-2 Vaccines and Are under Treatment with High-Efficacy Therapies in Argentina.” Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 45 (2): 379–89. doi:10.1007/s10072-023-07282-x.